genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Basal cell carcinoma
Cancer
How Cancer Derails a Stem Cell’s Fate
Cancer
Researchers Shed Light on Genetic Switch in Melanoma
Cancer
FDA Clears Roche’s Erivedge for Treating Advanced Basal Cell Carcinoma
Cancer
Pivotal Study Results Lead Genentech to Project Vismodegib Filing in U.S. During 2011
Cancer
Genentech and Curis’ Basal Cell Carcinoma Drug Meets Primary Endpoint in Pivotal Study
Cancer
Research Implicates Hair Follicle Stem Cells in Wound Healing-Related Basal Cell Carcinoma
Insights
Pharmacogenomics on Its Way Toward Clinic
News
Skin Lesions Linked to Basal Cell Carcinoma
News
Genentech Grants Ex-U.S. Rights Covering a Mid-Stage Cancer Drug to Roche
Resources
Finding Modulators of the Hh Pathway
Scroll Up
Scroll Up
